2022 Update on the Treatment of Pituitary Tumors


2022 Update on the Treatment of Pituitary Tumors Banner

Add to Calendar 2022 Update on the Treatment of Pituitary Tumors 4/9/2022 8:45:00 AM 4/9/2022 4:30:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?P=0&EID=29996 Description: This live virtual symposium will present recent advances in the diagnosis and treatment of pituitary diseases, including emerging therapies and innovations in the field. Complimentary registration for patients and caregivers. Online false MM/DD/YYYY


Date & Location
Saturday, April 9, 2022, 8:45 AM - 4:30 PM, Online, (EST) New York, NY

Specialties
Specialties - Endocrinology, Diabetes and Metabolism, ENT, Head and Neck Oncology, Head and Neck Surgery, Integrative Medicine, Internal Medicine, Neuro-Oncology, Neuroradiology, Neurosurgery, Nursing, Otolaryngology, Patient or Caregiver

Overview

Dr. Eliza Geer welcomes you to the 2022 Update on the Treatment of Pituitary Tumors.

This didactic and case-based educational course will update attendees on the latest developments in ongoing basic and translational science as well as the clinical management of patients with pituitary conditions. This course aims to improve patient care and outcomes through evidence-based discussion of clinical practice guidelines and emerging therapies. Our goal is to assess and update current practices to promote earlier diagnosis and treatment of pituitary diseases. The multidisciplinary nature of the course will allow for the dissemination of knowledge across the variety of practitioners caring for patients with pituitary diseases, and for the patients themselves.

Provider/Clinical Track (Request for Case Submissions)

There will be a tumor board during the provider/clinical breakout session where attendees and faculty will review cases. Attendees will have an opportunity to submit a case for discussion during the course at registration. In order to prepare your submission, we ask that you provide a BRIEF summary of your case and include key lab results. Please ensure that all identifiable PHI has been removed. Cases should have an educational purpose. The course faculty will not be able to provide a detailed/complex consult review during the course and they will try to get through as many cases as possible.

Patient Track (Complimentary Registration for Patients)

We also invite patients with pituitary disease and their caregivers to attend this educational activity and participate in our interactive afternoon breakout sessions. Pituitary patients will be able to review treatment options, learn about ongoing clinical trials, and discuss their comprehensive care with providers and other patients. The educational objective of this patient session is to provide a forum for pituitary patients to discuss treatment options and new therapies with providers and other patients. Please note AMA PRA Category 1 Credits™ will not be offered for the patient breakout session. MSK is pleased to invite patients and caregivers to attend this course on a complimentary basis. If you are a patient or caregiver interested in attending, please email [email protected] to register (registration is required in order to attend).

Who Should Attend

This course is intended for endocrinologists, neurosurgeons, otolaryngologists, radiation oncologists, neurologists, ophthalmologists, neuro-oncologists, family medicine and internal medicine physicians, physicians in training and other allied health professionals who treat and manage patients with pituitary diseases. We also invite patients with pituitary disease and their caregivers to attend this educational activity and participate in our interactive afternoon breakout sessions.

Live Virtual Format

This live virtual program will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). CME credit will be offered for this live virtual program. Detailed access and credit instructions will be emailed to attendees prior to the start of the course.


Objectives
  1. Summarize ongoing clinical trials and emerging therapies for the treatment of Cushing’s and acromegaly
  2. Discuss surgical outcomes, complications and risk management for pituitary and skull base tumors
  3. Evaluate endoscopic surgery with the use of patient reported outcomes
  4. Discuss integrative therapies and use of patient reported outcomes for pituitary patients
  5. Present recent data on mechanisms and biomarkers for the development of aggressive and malignant pituitary tumors
  6. Debate treatment decisions supporting the use and timing of new therapies for aggressive and malignant pituitary tumors
  7. Review mechanisms, diagnosis and treatment of immunotherapy-induced hypophysitis

Registration

Virtual Registration Fees

  • Physicians (MDs, PhDs and DOs): $150
  • Residents, Fellows, Advanced Practice Providers, Nurses, and Other Healthcare Providers: $100
  • Industry Professionals*: $265
  • Patients and Caregivers: Complimentary; please email [email protected] to register.

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Discounts/Promotions

  • A registration discount is available for MSK Alumni, MSK Cancer Alliance, and Cancer Care Partners to attend a MSK CME course. If you are a member of one of these groups, contact [email protected] for details.
  • Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify [email protected].

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Online Registration Deadline 

Online registration is available on the MSK CME Portal until 6:00 AM on April 9, 2022. If you wish to register after this date, please email [email protected] and we will ensure your registration is processed as well as access instructions are emailed to you prior to the start of the course. 

Cancellation Policy

For all other registrations: If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Endorsed by:
Cushing’s Support & Research Foundation (CSRF)
Acromegaly Community